Show simple item record

Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine

dc.contributor.authorVURAL, Pervin
dc.contributor.authorOkan, Gokhan
dc.date.accessioned2023-02-21T10:05:47Z
dc.date.available2023-02-21T10:05:47Z
dc.date.issued2022
dc.identifier.citationOkan G., VURAL P., "Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine", Dermatologic Therapy, cilt.35, sa.3, 2022
dc.identifier.issn1396-0296
dc.identifier.othervv_1032021
dc.identifier.otherav_3c25feda-3649-4686-93c9-98fe67b08e10
dc.identifier.urihttp://hdl.handle.net/20.500.12627/188092
dc.identifier.urihttps://doi.org/10.1111/dth.15280
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122015901&origin=inward
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDermatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectDERMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleWorsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine
dc.typeMakale
dc.relation.journalDermatologic Therapy
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Temel Tıp Bilimleri Bölümü
dc.identifier.volume35
dc.identifier.issue3
dc.contributor.firstauthorID4196847


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record